Estrogen receptor α gene polymorphisms and endometrial cancer risk

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 623-627

  Weiderpass, Elisabete ^a   Persson, Ingemar ^a   Melhus, Håkan ^b   Wedrén, Sara ^a   Kindmark, Andreas ^b   Baron, John A ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOMETRIUM CANCER; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SWEDEN;

EID: 0034052575     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.623     Document Type: Article

References (28)

1. Sano, M., Inoue, S., Hosoi, T., Ouchi, Y., Emi, M., Shiraki, M. and Orimo, H. (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem. Biophys. Res. Commun., 217, 378-383.
2. Kobayashi, S., Inoue, S., Hosoi, T., Ouchi, Y., Shiraki, M. and Orimo, H. (1996) Association of bone mineral density with polymorphism of the estrogen receptor gene. J. Bone Miner. Res., 11, 306-311.
3. Mizunuma, H., Hosoi, T., Okano, H., Soda, M., Tokizawa, T., Kagami, I., Miyamoto, S., Ibuki, Y., Inoue, S., Shiraki, M. and Ouchi, Y. (1997) Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone, 21, 379-383.
4. Han, K.O., Moon, I.G., Kang, Y.S., Chung, H.Y., Min, H.K. and Han, I.K. (1997) Association of estrogen receptor genotypes with the mineral density and estrogen responsiveness to hormone replacement therapy in korean postmenopausal women. J. Clin. Endocrinol. Metab., 82, 991-995.
5. Ongphiphadhanakul, B., Rajatanavin, R., Chanprasertyothin, S., Piaseu, N., Chailurkit, L., Sirisriro, R. and Komindir, S. (1998) Estrogen receptor gene polymorphism is associated with bone mineral density in premenopausal women but not in postmenopausal women. J. Endocrinol. Invest., 21, 487-493.
6. Willing, M., Sowers, M., Aron, D., Clark, M.K., Burns, T., Bunten, C., Crutchfield, M., D'Agostino, D. and Jannausch, M. (1998) Bone mineral density and its change in white women: estrogen and vitamin D receptor gene genotypes and their interaction. J. Bone Miner. Res., 13, 695-705.
7. Gennari, L., Becherini, L., Masi, L., Mansani, R., Gonnelli, S., Cepollaro, C., Martini, S., Montagnani, A., Lentini, G., Becorpi, A.M. and Brandi, M.L. (1998) Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J. Clin. Endocrinol. Metab., 83, 939-944.
8. Parl, F.F., Cavener, D.R. and Dupont, W.D. (1989) Genomic DNA analysis of the estrogen receptor gene in breast cancer. Breast Cancer Res. Treat., 14, 57-64.
9. Yaich, L., Dupont, W.D., Cavener, D.R. and Parl, F.F. (1992) Analysis of the Pvu II restriction fragment-lengh polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res., 52, 77-83.
10. McGuire, W.L., Chamness, G.C. and Fuqua, S.A.W. (1992) Abnormal estrogen receptor in clinical breast cancer. J. Steroid. Biochem. Mol. Biol., 43, 243-247.
11. Andersen, T.I., Heimdal, K.R., Skrede, M., Tveit, K., Berg, K. and Børresen, A.-L. (1994) Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum. Genet., 94, 665-670.
12. Roodi, N., Bailey, L.R., Kao, W.-Y., Verrier, C.S., Yee, C.J., Dupont, W.D. and Parl, F.F (1995) Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl Cancer Inst., 87, 446-451.
13. Key, T.J.A. and Pike, M.C. (1988) The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br. J. Cancer, 57, 205-212.
14. Castagnoli, A., Maestri, I., Bernardi, F. and Del Senno, L. (1987) Pvu II RFLP inside the human estrogen receptor gene. Nucleic Acids Res., 15, 866.
15. Del Senno, L., Aguiari, G.L. and Piva, R. (1992) Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene. Hum. Mol. Genet., 1, 354.
16. The National Board of Health and Welfare (1998) Cancer Incidence in Sweden 1995. Socialstyrelsen, Stockholm, Sweden.
17. Holgersson, S., Kalrsson, J.Å., Kihlgren, A., Rosén, B., Savolainen, P. and Gyllensten, U. (1994) Fluorescent-based typing of the two short tandem repeat loci HUMTH01 and HUMACTBP2: reproducibility of size measurements and genetic variation in the Swedish population. Electrophoresis, 15, 890-895.
18. Breslow, N.E. and Day, N.E. (1980) Statistical Methods in Cancer Research. The Analysis of Case-Control Studies. IARC, Lyon, Vol. 1, pp. 192-246.
19. Weiderpass, E., Baron, J.A., Adami, H.-O., Magnusson, C, Lindgren, A., Bergström, R., Correia, N. and Persson, I. (1999) Low potency estrogen formulations and risk for endometrial cancer. Lancet, 353, 1824-1828.
20. Kan, Y.W. and Dozy, A.M. (1978) Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc. Natl Acad. Sci. USA, 75, 5631-5635.
21. Clark, J.H., Shrader, W.T. and O'Malley, B.M. (1992) Mechanisms of action of steroid hormones. In Wilson, J.D. and Foster, D.W. (eds) Textbook of Endocrinology. W.B. Saunders Co., New York, NY, pp. 35-90.
22. Turner, R.T., Riggs, B.L. and Spelsberg, T.C. (1994) Skeletal effects of estrogens. Endocr. Rev., 15, 275-300.
23. Farhat, M.Y., Lavigne, M.C. and Ramwell, P.W. (1996) The vascular protective effects of estrogen. FASEB J., 10, 615-624.
24. Beato, M., Herrlich, P. and Schultz, G. (1995) Steroid hormone receptors: many actors in search of a plot. Cell, 83, 851-857.
25. Cauley, J.A., Lucas, F.L., Kuller, L.H., Vogt, M.T., Browner, W.S. and Cummings, S.T., for the Study of Osteoporotic Fractures Research Group (1996) Bone mineral density and risk of breast cancer in older women. The study of osteoporotic fractures. J. Am. Med. Assoc., 276, 1404-1408.
26. Zhang, Y., Kiel, D.P., Kreger, B.E., Cupples, L.A., Ellison, R.C., Dorgan, J.F., Schatzkin, A., Levy, D. and Felson, D.T. (1997) Bone mass and the risk of breast cancer among postmenopausal women. N. Engl. J. Med., 336, 611-617.
27. Dotzlaw, H., Alkhalaf, M. and Murphy, L.C. (1992) Characterization of estrogen receptor variant mRNA from human breast cancers. Mol. Endocrinol., 6, 773-785.
28. Fuqua, S.A., Fitzgerard, S.D., Allred, D.G., Elledge, R.M., Nawaz, Z., Mcdonnell, D.P., O'Malley, B.W., Greene, G.L. and Mcguire, W.L. (1992) Inhibition of estrogen receptor action by a naturally occuring variant in human breast tumors. Cancer Res., 52, 483-486.